Colgate-Palmolive (NYSE: CL) reported Q4 EPS of $0.95, $0.04 better than the analyst estimate of $0.91. Revenue for the quarter came in at $5.23 billion versus the consensus estimate of $5.12 billion.

Based on current spot rates and including the estimated impact of tariffs announced and finalized as of January 28, 2026:

• The Company expects net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange.
• The Company expects organic sales growth to be 1% to 4%. This includes an approximately 20 basis point impact from our exit from the private label pet food business.
• On a GAAP basis, the Company expects gross profit margin expansion with advertising up on both a dollar basis and as a percentage of net sales and double-digit earnings per share growth.
• On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion with advertising up on both a dollar basis and as a percentage of net sales and low to mid-single-digit earnings per share growth.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.